Biodesix, Inc.
US ˙ NasdaqGM ˙ US09075X1081

Introduction

This page provides a comprehensive analysis of the known insider trading history of Scott Hutton. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Scott Hutton has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:BDSX / Biodesix, Inc. President & CEO, Director 728,824
US:SPNC / Spectranetics Corp. (The) General Manager, VI 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Scott Hutton. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases BDSX / Biodesix, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in BDSX / Biodesix, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2021-11-17 BDSX Hutton Scott 3,000 6.4583 3,000 6.4583 19,375 13 6.82 1,086 5.61
2020-10-30 BDSX Hutton Scott 5,500 18.0000 5,500 18.0000 99,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

BDSX / Biodesix, Inc. Insider Trades
Insider Sales BDSX / Biodesix, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in BDSX / Biodesix, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-08-13 BDSX Hutton Scott 3,772 0.4163 3,772 0.4163 1,570 0 0.3835 -123 -7.86
2025-05-13 BDSX Hutton Scott 1,887 0.3529 1,887 0.3529 666
2025-05-12 BDSX Hutton Scott 1,888 0.3594 1,888 0.3594 679
2025-02-11 BDSX Hutton Scott 83,660 0.9242 83,660 0.9242 77,319
2024-11-12 BDSX Hutton Scott 1,813 1.4008 1,813 1.4008 2,540
2024-11-11 BDSX Hutton Scott 1,927 1.3909 1,927 1.3909 2,680
2024-08-12 BDSX Hutton Scott 963 1.5719 963 1.5719 1,514
2024-08-09 BDSX Hutton Scott 2,781 1.6010 2,781 1.6010 4,452
2024-05-09 BDSX Hutton Scott 3,764 1.4795 3,764 1.4795 5,569
2024-02-12 BDSX Hutton Scott 29,708 1.6647 29,708 1.6647 49,455
2024-02-09 BDSX Hutton Scott 34,682 1.9166 34,682 1.9166 66,472
2023-11-10 BDSX Hutton Scott 1,883 1.2256 1,883 1.2256 2,308
2023-11-09 BDSX Hutton Scott 1,882 1.2707 1,882 1.2707 2,391
2023-08-10 BDSX Hutton Scott 6,889 1.2669 6,889 1.2669 8,728
2023-08-09 BDSX Hutton Scott 6,893 1.3883 6,893 1.3883 9,570
2023-05-10 BDSX Hutton Scott 3,848 1.5761 3,848 1.5761 6,065
2023-05-09 BDSX Hutton Scott 9,934 1.5664 9,934 1.5664 15,561
2023-02-09 BDSX Hutton Scott 16,278 1.7991 16,278 1.7991 29,286
2022-11-10 BDSX Hutton Scott 6,087 1.0175 6,087 1.0175 6,194
2022-11-09 BDSX Hutton Scott 7,690 1.0418 7,690 1.0418 8,011
2022-08-09 BDSX Hutton Scott 13,634 2.5282 13,634 2.5282 34,469
2022-05-10 BDSX Hutton Scott 13,278 1.8300 13,278 1.8300 24,299

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

BDSX / Biodesix, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Scott Hutton as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-08-14 2025-08-13 4 BDSX BIODESIX INC
Common Stock
S - Sale -3,772 728,824 -0.51 0.42 -1,570 303,409
2025-08-14 2025-08-12 4 BDSX BIODESIX INC
Common Stock
M - Exercise 12,212 732,596 1.70
2025-05-13 2025-05-13 4 BDSX BIODESIX INC
Common Stock
S - Sale -1,887 720,384 -0.26 0.35 -666 254,224
2025-05-13 2025-05-12 4 BDSX BIODESIX INC
Common Stock
S - Sale -1,888 722,271 -0.26 0.36 -679 259,584
2025-05-13 2025-05-09 4 BDSX BIODESIX INC
Common Stock
M - Exercise 12,212 724,159 1.72
2025-02-12 2025-02-11 4 BDSX BIODESIX INC
Common Stock
S - Sale -83,660 701,947 -10.65 0.92 -77,319 648,739
2025-02-12 2025-02-10 4 BDSX BIODESIX INC
Common Stock
M - Exercise 252,628 785,607 47.40
2024-11-13 2024-11-12 4 BDSX BIODESIX INC
Common Stock
S - Sale -1,813 532,979 -0.34 1.40 -2,540 746,597
2024-11-13 2024-11-11 4 BDSX BIODESIX INC
Common Stock
S - Sale -1,927 534,792 -0.36 1.39 -2,680 743,842
2024-11-13 2024-11-08 4 BDSX BIODESIX INC
Common Stock
M - Exercise 12,212 536,719 2.33
2024-08-12 2024-08-12 4 BDSX BIODESIX INC
Common Stock
S - Sale -963 518,368 -0.19 1.57 -1,514 814,823
2024-08-12 2024-08-09 4 BDSX BIODESIX INC
Common Stock
S - Sale -2,781 519,331 -0.53 1.60 -4,452 831,449
2024-08-12 2024-08-08 4 BDSX BIODESIX INC
Common Stock
M - Exercise 12,212 522,112 2.39
2024-05-23 2024-05-23 4 BDSX BIODESIX INC
Common Stock
M - Exercise 26,120 509,900 5.40
2024-05-10 2024-05-09 4 BDSX BIODESIX INC
Common Stock
S - Sale -3,764 483,780 -0.77 1.48 -5,569 715,753
2024-05-10 2024-05-08 4 BDSX BIODESIX INC
Common Stock
M - Exercise 12,212 487,544 2.57
2024-02-12 2024-02-12 4 BDSX BIODESIX INC
Common Stock
S - Sale -29,708 465,011 -6.01 1.66 -49,455 774,104
2024-02-12 2024-02-09 4 BDSX BIODESIX INC
Common Stock
S - Sale -34,682 494,719 -6.55 1.92 -66,472 948,178
2024-02-12 2024-02-08 4 BDSX BIODESIX INC
Common Stock
M - Exercise 199,973 529,401 60.70
2023-11-13 2023-11-10 4 BDSX BIODESIX INC
Common Stock
S - Sale -1,883 329,428 -0.57 1.23 -2,308 403,747
2023-11-13 2023-11-09 4 BDSX BIODESIX INC
Common Stock
S - Sale -1,882 331,311 -0.56 1.27 -2,391 420,997
2023-11-13 2023-11-08 4 BDSX BIODESIX INC
Common Stock
M - Exercise 12,212 333,193 3.80
2023-08-10 2023-08-10 4 BDSX BIODESIX INC
Common Stock
S - Sale -6,889 318,013 -2.12 1.27 -8,728 402,891
2023-08-10 2023-08-09 4 BDSX BIODESIX INC
Common Stock
S - Sale -6,893 324,902 -2.08 1.39 -9,570 451,061
2023-08-10 2023-08-08 4 BDSX BIODESIX INC
Common Stock
M - Exercise 44,777 331,795 15.60
2023-08-07 2023-08-03 4 BDSX BIODESIX INC
Common Stock
A - Award 46,296 287,018 19.23 1.62 75,000 464,969
2023-05-10 2023-05-10 4 BDSX BIODESIX INC
Common Stock
S - Sale -3,848 240,722 -1.57 1.58 -6,065 379,402
2023-05-10 2023-05-09 4 BDSX BIODESIX INC
Common Stock
S - Sale -9,934 244,570 -3.90 1.57 -15,561 383,094
2023-05-10 2023-05-08 4 BDSX BIODESIX INC
Common Stock
M - Exercise 44,778 254,504 21.35
2023-02-10 2023-02-09 4 BDSX BIODESIX INC
Common Stock
S - Sale -16,278 199,726 -7.54 1.80 -29,286 359,327
2023-02-10 2023-02-08 4 BDSX BIODESIX INC
Common Stock
M - Exercise 44,777 216,004 26.15
2022-11-21 2022-11-21 4 BDSX BIODESIX INC
Common Stock
A - Award 65,217 171,227 61.52 1.15 75,000 196,911
2022-11-10 2022-11-10 4 BDSX BIODESIX INC
Common Stock
S - Sale -6,087 106,010 -5.43 1.02 -6,194 107,865
2022-11-10 2022-11-09 4 BDSX BIODESIX INC
Common Stock
S - Sale -7,690 112,097 -6.42 1.04 -8,011 116,783
2022-11-10 2022-11-08 4 BDSX BIODESIX INC
Common Stock
M - Exercise 44,778 119,787 59.70
2022-08-10 2022-08-09 4 BDSX BIODESIX INC
Common Stock
S - Sale -13,634 75,009 -15.38 2.53 -34,469 189,638
2022-08-10 2022-08-08 4 BDSX BIODESIX INC
Common Stock
M - Exercise 44,777 88,643 102.08
2022-05-11 2022-05-10 4 BDSX BIODESIX INC
Common Stock
S - Sale -13,278 43,866 -23.24 1.83 -24,299 80,275
2022-05-11 2022-05-09 4 BDSX BIODESIX INC
Restricted Stock Units
M - Exercise -32,566 162,827 -16.67
2022-05-11 2022-05-09 4 BDSX BIODESIX INC
Restricted Stock Units
M - Exercise -12,212 183,180 -6.25
2022-05-11 2022-05-09 4 BDSX BIODESIX INC
Common Stock
M - Exercise 44,778 57,144 362.11
2022-03-14 2022-03-10 4 BDSX BIODESIX INC
Stock Options (Right to buy)
A - Award 85,875 85,875
2022-03-14 2022-03-10 4 BDSX BIODESIX INC
Stock Options (Right to buy)
A - Award 8,423 16,846 100.00
2022-03-14 2021-02-23 4 BDSX BIODESIX INC
Stock Options (Right to buy)
A - Award 8,423 8,423
2022-02-10 2022-02-08 4 BDSX BIODESIX INC
Restricted Stock Units
A - Award 195,393 195,393
2022-02-10 2022-02-08 4 BDSX BIODESIX INC
Restricted Stock Units
A - Award 195,392 195,392
2021-11-18 2021-11-17 4 BDSX BIODESIX INC
Common Stock
P - Purchase 3,000 9,762 44.37 6.46 19,375 63,046
2020-11-03 2020-10-30 4 BDSX BIODESIX INC
Common Stock
P - Purchase 5,500 5,500 18.00 99,000 99,000
2017-08-11 2017-08-09 4 SPNC SPECTRANETICS CORP
Performance Stock Units
D - Sale to Issuer -7,736 0 -100.00 38.50 -297,836
2017-08-11 2017-08-09 4 SPNC SPECTRANETICS CORP
Restricted Stock Units
D - Sale to Issuer -15,473 0 -100.00 38.50 -595,710
2017-08-11 2017-08-09 4 SPNC SPECTRANETICS CORP
Stock Option (Righ to Buy)
D - Sale to Issuer -8,464 0 -100.00 12.65 -107,070
2017-02-09 2017-01-31 4 SPNC SPECTRANETICS CORP
SPNC Common Stock
A - Award 8,465 8,465
2017-02-09 2017-01-31 4 SPNC SPECTRANETICS CORP
SPNC Restricted Stock Unit
A - Award 15,474 15,474
2017-02-09 3 SPNC SPECTRANETICS CORP
No securities are beneficially owned.
0
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)